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in developing advanced molecular sensors for biomedical and environmental applications. Herein, we 
introduce the horseradish peroxidase (HRP)-like activity of gold-loaded nanoporous ferric oxide 
nanocubes (Au-NPFe2O3NC) for the development of a molecular sensor with enhanced electrocatalytic 
and colorimetric (naked eye) detection of autoantibodies. The results showed that Au-NPFe2O3NC 
exhibits enhanced peroxidase-like activity toward the catalytic oxidation of 3,3′,5,5′-tertamethylbenzidine 
(TMB) in the presence of H2O2 at room temperature (25 °C) and follows the typical Michaelis-Menten 
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p53-specific autoantibody in plasma obtained from patients with epithelial ovarian cancer high-grade 
serous subtype (EOCHGS, number of samples = 2) and controls (benign, number of samples = 2). As Au-
NPFe2O3NC possess high peroxidase-like activity for the oxidation of TMB in the presence of H2O2 [TMB 
is a common chromogenic substrate for HRP in enzyme-linked immunosorbent assays (ELISAs)], we 
envisage that our assay could find a wide range of application in developing ELISA-based sensing 
approaches in the fields of medicine (i.e., detection of other biomarkers the same as p53 autoantibody), 
biotechnology, and environmental sciences. 
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ABSTRACT 
Enzyme-mimicking activity of iron oxide based nanostructures have provided a significant 
advantage in developing advanced molecular sensors for biomedical and environmental 
applications. Herein, we introduce the horseradish peroxidase (HRP)-like activity of gold 
loaded nanoporous ferric oxide nanocubes (Au-NPFe2O3NC) for the development of a 
molecular sensor with enhanced electrocatalytic and colorimetric (naked-eye) detection of 
autoantibodies. The results showed that Au-NPFe2O3NC exhibits enhanced peroxidase-like 
activity towards the catalytic oxidation of 3,3ˊ,5,5ˊ-tertamethylbenzidine (TMB) in the 
presence of H2O2 at room temperature (25°C) and follows the typical Michaelis–Menten 
kinetics. The autoantibody sensor based on this intrinsic property of Au-NPFe2O3NC resulted 
excellent detection sensitivity (LOD = 0.08 U/mL) and reproducibility (% RSD = < 5% for n 
= 3) for analysing p53-specific autoantibodies using electrochemical and colorimetric (naked-
eye) readouts. The clinical applicability of the sensor has been tested in detecting p53-
specific autoantibody in plasma obtained from patients with epithelial ovarian cancer high-
grade serous subtype (EOCHGS, number of samples = 2) and controls (benign, number of 
samples = 2). As Au-NPFe2O3NC possess high peroxidase-like activity for the oxidation of 
TMB in the presence of H2O2 (TMB is a common chromogenic substrate for HRP in 
ELISAs), we envisage that our assay could find a wide range of application in developing 
ELISA based sensing approaches in the field of medicine (i.e. detection of other biomarkers 
same as p53 autoantibody), biotechnology and environmental sciences.  
  
1. Introduction 
Iron oxide (IO) nanostructures have widely been used in a variety of biomedical applications, 
such as tissue engineering, magnetic resonance imaging, hyperthermia, drug and gene 
targeting, isolation and separation of proteins or cells from samples, and in-vivo cell 
tracking.
1,2
 The paramagnetic properties of IO nanoparticles also allows for contactless 
sample preparation and handling using the emerging technology of micromagnetofluidics.
3
  
In recent years, it has been demonstrated that IO based nanoparticles (NPs) possess an 
intrinsic horseradish peroxidase (HRP)-mimicking activity towards the oxidation of common 
chromogenic substances such as 3,3ˊ,5,5ˊ-tertamethylbenzidine (TMB), di-azo-
aminobenzene, and o-phenylenediamine , which have widely been used in catalytic 
decomposition of hydrogen peroxides or developing non-enzymatic glucose sensors.
4,5,6
 For 
instance, peroxidase-like activity of Fe2O3, prussian blue/Fe2O3, graphene/Fe2O3, 
GO_MNP(Fe3O4)/Pt, ZnFe2O4NPs have extensively been used to develop several high 
performance biosensors for detecting glucose, H2O2, cancer cells, L-cysteine etc.
7,8,9,10,11
 
Similar to IO based NPs, other nanomaterials such as AuNPs, Eu2O2SNPs, CuONPs, copper–
creatinine complex, AgX (X= Cl, Br, I), polyoxometalates, PtNPs, carbon nanotubes and 
nanodots have also been reported to exhibit peroxidase-like activity.
6,12,13,14,15,16,17,18,19
 The 
use of these peroxidase-mimetic nanomaterials for developing biosensors is highly attractive 
due to several reasons. First, unlike natural peroxidase (i.e., HRP) they are stable towards 
protease digestion or denaturation, and their structure, morphology and function are not 
affected by environmental stresses.
20
 Second, they are relatively easy and inexpensive to 
prepare and highly suitable for benchtop storage and handling. Despite these advantages, 
most of these materials demonstrate their highest peroxidase-like activity at higher 
temperature (40 – 45 °C), which limits their applications in disease specific biomolecules 
detection at room temperature. Therefore, design and synthesis of NPs with enhanced 
peroxidase-mimetics activity at room temperature are highly desirable.  
Recently, we have synthesized a new class of gold-loaded superparamagnetic ferric 
oxide nanocube (Au-NPFe2O3NC).
21
 This Au-NPFe2O3NC exhibits multiple functionalities. 
First, it shows enhanced catalytic activity towards the common electroactive molecules (i.e., 
hexaammineruthenium(III) chloride, (Ru(NH3)6Cl3)).
22
 Second, highly porous framework of 
gold loaded Fe2O3 nanocubes allows for the direct adsorption of large amount of target DNA, 
RNA or protein via gold-DNA/RNA/Proteins affinity interactions.
23,24,25,26
  Third, as these 
nanocubes are paramagnetic, they can be used as dispersible capture vehicles to isolate the 
circulating biomarkers in body fluids (i.e., they can be dispersed into the sample and bind to 
the analytes of interest).
21
 As the capture event of the target analytes of interest temporally 
and spatially separated from the electrochemical measurement, this alleviates biofouling 
issues of the electrode. The Au-NPFe2O3NC nanocubes also provide a mean to reduce the 
biological noises associated with adsorption of non-specific species present in the body fluids 
via magnetic enrichment, separation, and purification steps.
1
 Fourth, the Au-NPFe2O3NC 
nanocubes can also be used as nanoenzymes with enhanced peroxidase-like activity. 
Although the functionalities of Au-NPFe2O3NC as electrocatalyst and dispersible capture 
vehicle have already been explored,
21,22
 the peroxidase-like activity of Au-NPFe2O3NC has 
yet to be demonstrated. In this paper, we studied this peroxidase-like activity for the 
development of a proof-of-concept molecular sensor for detecting circulating autoantibodies 
in serum or plasma samples.  
Circulating autoantibodies that are elicited in responses to tumor-associated antigen 
(TAA) are emerging biomarkers for the early detection of cancer, as they are produced by the 
patient’s immune system long (several months or years) before the onset of the clinical 
symptoms of diseases.
27,28,29
 The direct quantification of TAAs in clinical samples possess 
severe challenges due to their low abundance and associated difficulties in identifying minor 
structural modification or mutation. In contrast, serum autoantibodies are relatively more 
stable (i.e., longer half-lives due to limited proteolysis and clearance) and present as large 
quantities in clinical samples
 
and therefore they have been used as circulating reporters for 
the early or pre-clinical detection of various cancers including ovarian, lung, and breast 
cancer.
30,31,32,33,34 
It is also important to note that, with the progression of the cancer (stages), 
the amount of autoantibody (produced) compared to that of TAAs is highly significant and 
readily detectable with the conventional detection techniques.
35
  
Most of the widely used methods for serum autoantibody detection are mainly based 
on ELISA or protein arrays that employ HRP conjugated protein specific secondary 
antibodies to read the target autoantibody.
31,32,33,34,35,36,37 
These methods are however, 
expensive, relatively less sensitive and can only provide qualitative or semi-quantitative 
results. Until recently, the most advanced assay for the sensitive detection of serum 
autoantibody is that developed by Asensio et al., where HaloTag fusion p53 protein modified 
commercial magnetic beads (MBs) were used as magnetic microcarriers for capturing the 
autoantibodies in sera.
38
 HRP conjugated anti-human IgG was then used to quantify captured 
autoantibody via colorimetry and amperometry. More recently, we have also developed a 
method using Au-NPFe2O3NC as a dispersible capture agent for autoantibody isolation and 
detection.
21
 Although the analytical performance of these methods are superior, they still rely 
on HRP-based enzymatic reaction. 
Herein, we first studied the peroxidase-like activity of Au-NPFe2O3NC nanocubes 
towards the catalytic oxidation of TMB in the presence of H2O2. This feature of Au-
NPFe2O3NC was then used to develop a molecular sensor for the colorimetric (naked-eye) 
and electrochemical detection of p53 autoantibody in serum or plasma samples. The method 
was first tested on the sample obtained from commercial p53 ELISA kit and finally 
challenged with a small cohort of plasma samples derived from epithelial ovarian cancer 
high-grade serous subtype (EOCHGS).  
EXPERIMENTAL SECTION 
Study group and ovarian cancer samples. Staged samples (cross sectional) were collected 
at the Ochsner Baptist Medical Center in the clinical trials and obtained via The UQ Centre 
for Clinical research. Plasma samples were obtained in accordance with the declaration of 
Helsinki and approved by the Ethics Committee of The University of Queensland and the 
Ochsner Medical Center (New Orleans, USA). Plasma was separated from whole blood by 
centrifugation (2000 g x 10 min at Room temperature) and stored at -80 
o
C until analyses. 
Ovarian cancer samples were collected prospectively and assigned according to the 
hystotypes classification (e.g. stage I, and stage III) and stored to -80 °C in the Biobank units. 
Only patients with epithelial ovarian cancer high-grade serous subtype (n = 2) and benign 
controls (n = 2) were included in this study. 
Peroxidase-mimetic activity of Au-NPFe2O3NC. Unless otherwise stated, the peroxidase-
like activity of Au-NPFe2O3NC were carried out at room temperature using 5 µg of Au-
NPFe2O3NC in 80 µL of reaction buffer (0.2 M sodium acetate (NaAc), pH 3.5) in the 
presence of 800 µM freshly prepared TMB (TMB dissolved in DMSO) and 700 mM H2O2. 
The formation of blue coloured solution was monitored and measured in time scan mode at 
652 using a spectrophotometer (SpectraMax). The reaction was quenched by adding 2.0 µL 
of stop solution. The end point of resultant yellow colour product was measured using 
colorimetry (at 452 nm) and chronoamperometry.  The steady-state kinetic assays were 
carried out using standard reaction condition (described above) by varying the concentration 
of H2O2 (0.01 to 1.1 M) at a fixed concentration of TMB (800 µM) and vice versa for the 
varying the concentration of TMB (0.01 to 1.0 mM) at 700 mM H2O2. The apparent kinetic 
parameters was calculated by considering a typical enzyme catalytic reaction; 
 
 
where E, S, ES and P represent the enzyme, substrate, enzyme substrate adduct and product 
respectively. The Michaelis-Menten equation for the catalytic system is expressed as 
follows,
39
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In this equation, Vo is the rate of substrate conversion to product, Vmax is the maximum rate of 
conversion, which is attained when the active (catalytic) sites on the enzyme are saturated 
with substrate, [S] is the substrate concentration, and Km is the Michaelis-Menten constant 
(denotes the affinity of enzyme for the substrate), which is equivalent to the substrate 
concentration at the conversion rate is half of Vmax. The rearrangement of Michaelis-Menten 
equation gives the Lineweaver–Burk equation,
40
 which was used to determine enzyme 
kinetics terms Km and Vmax. 
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Colorimetric and amperometric detection of serum p53 autoantibody. The SPCE-XTR 
was kept at room temperature for 1 h and washed with PBS.  5.0 μL (100 ng/mL) p53 antigen 
was incubated onto the electrode surface for 40 min. After the incubation, the electrode 
surface was washed with PBS three times followed by further incubation with 1% BSA 
solution (blocking agent) for 15 min. 5.0 μL of diluted serum sample or tested serum sample 
(1:100 dilution) were then added to the electrode surface and incubated for 1 h to capture the 
p53-specific autoantibodies present in the sample. After washing away the unbounded or 
loosely attached serum proteins with PBS, the complex is  incubated with 5.0 μL of freshly 
prepared IgG/Au-NPFe2O3NC for 40 min followed by several PBS wash to remove all 
unbounded IgG/Au-NPFe2O3NC. Finally, 50 μL of freshly prepared TMB substrate solution 
(800 µM TMB, 700 mM H2O2 in 0.2 M NaAc buffer, pH-3.5) was added and incubated for 
30 min in dark. The color change was visually observed. For quantitative measurements of 
the amount of oxidized TMB, 2.0 μL of stop solution (2.0 M HCl) was added and absorbance 
was recorded at 452 nm with the SpectraMax spectrophotometer. For the electrochemical 
detection, 30 μL of the oxidized TMB solution was pipetted onto another clean SPE-Au, and 
amperometric response (i-t) were measured at 150 mV over 120 s. At least three replicates 
were measured for each standard/sample. All measurements were performed at room 
temperature. 
 
RESULT AND DISCUSSION 
Peroxidase-mimetic activity of Au-NPFe2O3NC. It is now well established that natural 
peroxidase (HRP) can catalyse the oxidation of TMB in the presence of H2O2. This catalytic 
reaction generates two coloured products. First, HRP/H2O2 catalysed the oxidation of TMB 
that produced a blue-coloured charge-transfer complex of parent TMB (diamine) and TMB 
oxidised product (diimine), which could be used for qualitative (naked-eye) evaluation. 
Second, this blue-coloured complex turned yellow after the addition of an acid.
4,41 
The yellow 
product is electroactive and stable at acidic pH, thus can be quantified by UV-Vis (semi-
quantitative, colorimetry) and electrochemical detection methods. We have recently 
synthesized a novel class of superparamagnetic Au-NPFe2O3NC.
21,22
 The details 
characterization data of this material have already been described in references 21 and 22. 
Briefly, Au-NPFe2O3NC was synthesized by depositing AuNPs on to the nanoporous iron 
oxide nanocubes (NPFe2O3NCs) derived from Prussian blue (PB) nanocubes.
21,22 
Bright field 
TEM and HAADF-STEM images for this materials clearly showed that they possessed highly 
porous structure (Figure S1in Supporting Information). SEM images in Figure S2 
(Supporting Information) resulted that the Au content is well distributed over the entire 
particles. The peaks in the wide-angle XRD pattern are assignable to Au, α-Fe2O3, and γ-
Fe2O3 (Figure S3in Supporting Information). This material exhibits peroxidase-like activity 
for the oxidation TMB in the presence of H2O2 at room temperature. Figure 1(a), represents 
the mechanism of the catalysis of TMB (in presence of H2O2) oxidation reaction by Au-
NPFe2O3NC. 
To assess peroxidase-mimetics of nanocubes, a set of control experiments were 
conducted. TMB substrate solution in the presence (positive control) and absence (negative 
control) of nanocubes was incubated in dark. After 10 min of incubation, positive control 
sample generated a clear blue coloured solution, while negative control was colourless. 
Positive control gave an absorbance of 0.96 at 652 nm which is 15-times higher than that of 
negative control (abs. 0.96 versus 0.053) samples (Figure 1b). Addition of 2.0 M HCl into the 
solution, turned the blue-coloured complex to an electroactive yellow-coloured diimine 
product. The electrochemical quantification of oxidised product was conducted by placing the 
reaction mixture onto a screen-printed gold electrode (SPE-Au) via of amperometry. Figure 
1(c) shows the amperometric signals where positive control generated 86.78 µA cm
-2
 current 
density compared to that of negative control (4.59 µA cm
-2
). These experiments (i.e., naked 
eye observation, colorimetric and amperometric readouts) clearly confirm the peroxidase-like 
activity of our novel Au-NPFe2O3NC nanocubes. Notably, unlike most of the existing 
nanomaterials,
7,8,9,10,11,12,13,14,15,16,17,18
 which possess the highest peroxidase-like activity at 40 
– 45 °C, our Au-NPFe2O3NC nanocubes exhibit relatively enhanced activity at room 
temperature. The level of peroxidase-like activity of Au-NPFe2O3NC nanocubes at room 
temperature is sufficient enough to generate approximately 20-times higher response in 
compare with the negative control sample (Figure 1C). One possible explanation of this 
enhanced response could be due to (i) the large surface of the Au-NPFe2O3NC nanocubes 
(i.e., highly porous) that facilitates the binding of increased amount of positively charged 
TMB and hence the TMB/H2O2 reaction, and (ii) the presence of 2% AuNPs in the nanocubes 
that also catalyse the TMB/H2O2 reaction. In this nanocubes catalysed TMB/H2O2 reaction, 
ferric ions (from nanocubes) initiate the reaction by generating hydroxyl free radical (
.
OH) 
from H2O2 following the Fenton reaction.
42,43 
TMB is then oxidised by the generated 
.
OH, as 
shown below  
  HFeOOHOHFe 222
3    (1) 
  2
22 HOFeFeOOH     (2) 
OHOHFeOHFe   322
2    (3) 
 BlueTMBTMBOH ox     (4) 
 
Similar to HRP, the activity of Au-NPFe2O3NC is also dependent on the solution pH 
and amount of nanocubes. In order to check the effect of pH, we studied the peroxidase-like 
activity of nanocubes using different solution pH ranging from 2.5 to 5.5. We observed that 
with increasing pH of the solution the peroxidase-like activity of Au-NPFe2O3NC decrease 
(Figure S4a1 in Supporting Information). This is because addition of nanocubes may 
accelerate the processes (eqn. 1) and (eqn. 2) (see above) and produce excessive amount of 
2FeOOH and 2HO . At higher pH, 2HO  can be ionized to O2
-
, as shown by equation (eqn. 
5).
44
 The 2HO can also instantly react with hydroxyl radicals and produce oxygen (eqn. 6).  
  22. OHHO     (5) 
2222 / OOHOHOOH 

  (6) 
Among all studied pH values, pH 2.5 resulted the highest responses both in colorimetry and 
amperometric readouts. As the iron could be leached from the nanocubes in the solution pH 
of <3,
7
 we selected pH 3.5 as the optimal pH for conducting subsequent experiments in our 
study. To optimize the amount of nanocubes in our assay, 5 μL of designated concentrations 
(i.e., 2.5 (0.5 μg/μL), 5 (0.5 μg/μL), 10, (2 μg/μL) and 20 μg (4 μg/μL)) of nanocubes were 
used. As can be seen in Figure S4b1 (in Supplementary Information); 5, 10 and 20 μg of 
nanocubes produced almost similar responses both in colorimetry and amperometric 
readouts, and therefore we chose 5 μg as the optimal nanocube amount for subsequent 
experiments.  
 
Steady-State Kinetic for Au-NPFe2O3NC. To investigate the peroxidase-like activity of 
nanocubes, apparent steady-state kinetic parameters for TMB oxidation were determined by 
varying the concentration of H2O2 and TMB (Figure S5 in Supporting Information), a similar 
phenomenon commonly used for HRP enzymes.
2
 The experiments were carried out using 5 
μg nanocubes in a reaction volume of 60 µL (0.2 M NaAc buffer, pH 3.5) at room 
temperature. The kinetic parameters were estimated by initial rate method.
7,45
 The absorbance 
data were converted to corresponding concentration by the Beer-Lambert Law using the 
value of ɛ = 39,000 M
-1
cm
-1
 (at 652 nm) for the oxidized product of TMB.
46
 Typical 
Michaelis-Menten-like curve was obtained within the suitable concentration range for both 
H2O2 (Figure 2a) and TMB (Figure 2b). To obtain the catalytic parameters (Michaelis-
Menten constant (Km) and maximum velocity (Vmax)), the data were fitted to Michaelis-
Menten- kinetic model using a nonlinear least square fitting.
39
 All kinetic parameters were 
also calculated from the Lineweaver-Burk double reciprocal plot (1/ velocity [Vo] versus 
1/substrate concentration [S]) (inset of Figure 2),
40
 and compared with that for previously 
reported peroxidase-mimetic nanoparticles (Table S1 in Supporting Information). Km is an 
indicator of enzyme affinity towards its substrate and a lower Km indicates the stronger 
affinity between enzymes and substrates. The apparent Km value for Au-NPFe2O3NC with 
TMB was lower than HRP, suggesting that the nanocubes has higher affinity with TMB in 
compare to the HRP.
4 
Moreover, Km value with both TMB and H2O2 is also higher than that 
of non-porous Fe3O4 NPs.
4 
The enhanced peroxidase-activity of our nanocubes at room 
temperature can be related to the highly porous ferric oxide moiety with high surface area 
(exposure of more Fe(III) ions) and large pore volume that facilitates the increased mass 
transfer as well as enhances the kinetics of the reaction. Additionally, as outlined earlier for 
PB-Fe2O3, nanoporous structure of Au-NPFe2O3NC could be beneficial for increasing 
electron transfer from the top of the valence bond of Fe2O3 to the lowest unoccupied 
molecular orbital (LUMO) of H2O2.
47
 Moreover, transfer of lone-pairs electron density 
(charge transfer) from the amino group of TMB to vacant d-orbital of Fe
3+
 may also enhance 
the electron density and mobility of Au-NPFe2O3NC nanocubes.
8
 
Colorimetric and amperometric detection of autoantibody. Our assay for the detection of 
p53-specific autoantibody using peroxidase-mimetic Au-NPFe2O3NC nanocubes is 
schematically represented in Figure 3. Here, p53 antigen was used to selectively recognise 
and capture the p53-specific autoantibody present in serum and plasma samples. In this 
proof-of-concept assay, we have chosen p53 autoantibody, because mutation in TP53 
proteins is an early indicator of cancer and also found to be present in almost 80% of all 
carcinogenesis.
34
 In response to the expression and mutation of this protein, corresponding 
amount of p53-tumor antigen-associated autoantibodies (TAAb) are generated, which has 
been considered as a potential early diagnosis biomarker for ovarian (type-II) cancer.
9
 In our 
assay, first, neuravidin-modified screen-printed carbon electrode (SPCE) was modified with 
biotinylated p53 antigen through standard biotin-avidin chemistry. Bovine serum albumin 
(BSA) was then used to block the unreacted sites to reduce non-specific bindings of 
biomolecules followed by the incubation of serum or plasma samples containing target p53 
autoantibody. As protein has the strong affinity towards gold surface, we functionalized Au-
NPFe2O3NC with α-human IgG with nanocube to form IgG/Au-NPFe2O3NC 
nanocatalysts.
50,51
 These nanocatalysts were then added to the electrode surface to form 
immunocomplex with the target p53 autoantibody.  To achieve the readout signals, the 
electrode surface was incubated with the freshly prepared TMB/H2O2 solution. The 
nanocatalysts initiate the oxidation of TMB, thereby producing a blue-coloured charged-
transfer complex (one electron). After the addition of stop solution, the blue coloured product 
was converted to a stable, electroactive yellow coloured (diimine) product. The naked-eye 
observation of the generation of blue and subsequent yellow colours, demonstrated the 
presence of p53 positive autoantibody present in analytes. The intensity of the TMBOx is 
directly linked to the amount of nanocubes as well as amount of p53 autoantibody present 
onto the electrode surface. Qualitative evaluation was observed by naked-eyes. Colorimetric 
readout (semi-quantitative) was conducted by measuring absorbance of diimine product at 
452 nm. However, the diimine product is electroactive, which allows the further 
quantification of autoantibody by chronoamperometry.  
To evaluate the assay specificity and functionality, we performed our assay in both 
p53 positive and negative samples. Diluted serum samples from commercial ELISA kit 
(ELISA-kit, Dianova GmbH, Germany) containing p53 autoantibody was used as a positive 
sample and serum samples without p53 autoantibody was taken as negative sample.
52
 The 
p53 autoantibody concentration in diluted human plasma sample is 14 U/mL, where 1.0 U 
represents the p53 binding activity of 100 µL undiluted calibrator. We found that, positive 
samples containing 7.0 U/mL (1:1 Dilution) of p53 autoantibody gave an intense blue colour, 
while stoichiometric amount of negative samples remained colourless. As can be seen in 
Figure 4a, a 10-times higher absorbance (abs@452 nm) was observed for positive sample 
compared to that of negative sample (0.616 versus 0.0526). Chronoamperometric 
measurement of positive sample was found to be 16-times higher than that of negative one 
(36 versus 2.116 µA cm
-2
) (Figure 4b). Control experiment without IgG/Au-NPFe2O3NC 
nanocatalysts gave negligible responses in both absorbance (Abs@452 nm = 0.0526) and 
subsequent amperometric (1.9 µA cm
-2
) measurements. This can be explained by the fact that 
in the absence of nanocatalysts, TMB (in presence of H2O2) oxidation reaction does not occur 
thereby resulting negligible response. In another control experiment, we used only phosphate 
buffer instead of serum with p53 autoantibody sample. This experiment resulted slightly 
higher response than that of the control without nanocatalysts (Abs@452 nm.  0.0625 versus 
0.0526, and current 3.63 versus 1.9 µA cm
-2
). This may be due to a level of nonspecific 
interaction of nanocatalysts with surface attached p53 antigen. All these control experiments 
clearly demonstrated the good level of specificity of our assay towards the detection of p53 
autoantibody from serum samples with negligible background response. 
To evaluate the sensitivity of our assay, a series of diluted positive samples obtained 
via serial dilution (1:1 to 1:80; 7 U/mL to 0.0875 U/mL) was tested. We observed an 
increasing trend in both the absorbance and current response with the increasing 
concentration of target autoantibody (Figure 4). This is because, the higher amount of target 
p53 autoantibody could bound an increasing amount of nanocatalysts on the electrode surface 
which subsequently enhance the nanocatalysts mediated oxidation of TMB (in presence of 
H2O2) system. As shown in Figure 5a, the colorimetric responses increase linearly with the 
increasing concentration of serum samples, and the linear regression equation was estimated 
to be y = 0.04741x – 0.0226, with the correlation coefficient (r
2
) of 0.9684. The detection 
limit (LOD) was estimated by corresponding signal-to-noise ratio of 2.5,
52 
and was found to 
be 0.12 U/mL for the colorimetric readout. On the other hand, the linear regression equation 
for amperometric readout was estimated as y = 5.201x – 1.4849, with the r
2
 of 0.9961, 
confirming the relatively better sensitivity (LOD of 0.08 U/mL, Figure 5b) in compare to the 
colorimetric readout. A relative standard deviation (%RSD) of three different sensors for both 
the colorimetric and electrochemical readouts was estimated to be <5.0%, suggesting the 
good reproducibility of electrode surface modification, isolation of p53 autoantibody from 
serum samples, incubation of nanocatalysts onto the p53 autoantibody-attached electrode 
surface and nanocatalysts induced signal transduction protocols. This level of LOD and 
reproducibility of our colorimetric and electrochemical assay over a wide range of serum 
concentration clearly demonstrates that the peroxidase-like activity of Au-NPFe2O3NC 
nanocatalysts is sensitive and specific enough to detect autoantibody in p53 positive serum 
samples. Moreover, LOD for both readout systems are better than that of the conventional 
p53-ELISA kit (0.08 versus ~0.3 U/mL).
52
 These LODs are also better than that of a recently 
reported Halotag-fusion protein modification based electrochemical platform (0.08 versus 
0.34 U/mL).
38
 Therefore, our methods can detect much lower concentration of p53 
autoantibody than above reported methods. It is also important to note that the sensitivity of 
our recently reported HRP-based method
21 
is slightly better than that of the current method 
(i.e., 0.02 versus 0.08 U/mL) than that of the current method. However, our current method 
avoids the use of expensive HRP-based reaction system.
 
We further checked the applicability of our novel platform for the analysis of complex 
human plasma samples. The plasma samples were obtained from women with epithelial 
ovarian cancer high-grade serous subtype (stage I and III, P3 and P4 respectively) and 
controls (P1 and P2) (benign). Ovarian cancer in one of the leading causes of cancer-related 
death of woman from gynaecologic malignancy.
9
 It has been reported that, in response to the 
overexpression or mutation of protein (TP53) in ovarian cancers, p53-antigen specific 
autoantibodies are generated.
53
 TP53 mutation occurs early in high grade ovarian cancer and 
strongly attendant with the p53 autoantibodies.
35
 Thus, development of an early diagnosis 
platform for ovarian cancers via p53-autoantibody analysis can potentially decrease the 
disease burden as well as increase the overall survival. In this study, all clinical samples were 
diluted (1:100) prior performing the assay. As projected, both colorimetric and 
electrochemical methods response were higher in stage III patients (P4) sample than stage I 
(P3) (Figure 6). However, the assay can also differentiate the stage I response from the two 
non-cancerous healthy controls. Both of these healthy controls (P1 and P2) produced 
negligible signal suggesting the absence of p53 autoantibody. These clinical data showed a 
very good inter-assay reproducibility (RSD <5%, for n = 3) for the analysis of differential 
expression pattern of p53 autoantibodies in different stages of ovarian cancers. 
The naked-eye discrimination of the autoantibodies described here hold huge potential 
for the development of a user-friendly and inexpensive bioassay in resource-limited settings, 
where sophisticated scientific equipment is unavailable. In particular, this approach can be 
exploited as a rapid first-pass screening (yes/no) tool to detect clinically relevant 
autoantibodies in large population followed by more accurate and sensitive quantification of 
autoantibody via amperometric readout. The use of disposable SPE-Au successfully 
eliminates the need of a time-consuming electrode cleaning process typically used in 
conventional disk electrodes. The assay also replaces natural enzymes for TMB oxidation, 
and thus reduces the cost, handling and storage facilities generally required for natural 
enzymes. Overall, the assay platform is relatively inexpensive and portable (i.e., use of 
disposable and inexpensive SPE; replaces of relatively expensive HRP; avoids tedious 
cleaning of conventional disk electrodes).  Importantly, the application of this method is not 
limited to autoantibody detection, it could potentially be applied as an ideal alternative for 
conventional ELISA assays for the detection of many other clinically relevant protein 
biomarkers by changing the relevant antibodies in the antibody functionalisation steps of the 
assay. Taken together these benefits, we expect that this peroxidase-like activity of Au-
NPFe2O3NC nanocubes and their subsequent translation to p53 autoantibody detection assay 
may have wide application in human cancers or chronic disease.  
 
CONCLUSIONS 
We have introduced the peroxidase mimetics of a new class of Au-NPFe2O3NC nanocubes. 
We have shown that Au-NPFe2O3NC resulted the enhanced peroxidase-like activity and 
followed the Michaelis-Menten and Lineweaver-Burk models for the enzyme catalysed 
TMB/H2O2 reaction at room temperature (25 °C). The enhanced peroxidase-like activity was 
mainly due to the large surface of the Au-NPFe2O3NC nanocubes (i.e., highly porous) that 
facilitated the binding of increased amount of positively charged TMB and hence the 
TMB/H2O2 reaction. The presence of 2% AuNPs within the nanocube framework also 
contributed towards the catalysis of the TMB/H2O2 reaction. This intrinsic feature was further 
used to develop a new proof-of-concept platform for autoantibody detection body fluids 
samples using both colorimetric and electrochemical readout. This platform successfully 
detected the p53 autoantibodies in diluted serum and a small cohort of patients’ plasma 
samples with high sensitivity and specificity.  
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FIGURE CAPTIONS 
Figure 1. (a) Schematic illustration of peroxidase-mimicking activity of Au-NPFe2O3NC for 
the oxidation of TMB in the presence of H2O2. Mean values of (b) absorbance (UV-vis) and 
(c) amperometric current signals for the negative and positive control samples (inset in (b) 
and (c) are the corresponding photos for the naked eye evaluation and i-t curves respectively).  
 
Figure 2. Steady-state kinetic analyses using Michaelis-Menten model (main panel) and 
Lineweaver-Burk model (inset panel) for the Au-NPFe2O3NC nanocubes by varying 
concentration of (a) H2O2 (0.01 to 1.1 M) and (b) TMB (0.01 to 1.0 mM) with fixed amount 
of (a) TMB (800 µM) and (b) H2O2 (700 mM).  
 
Figure 3. Schematic representation of the assay for the detection of tumor-associated plasma 
(and serum) p53 auntoantibody. Extravidin modified screen-printed carbon electrode was 
functionlized with biotinylated p53. Serum/plasma samples containing p53-specific 
autoantibody was then incubated onto the electrode surface followed by the incubation with 
IgG/Au-NPFe2O3NC nanocatalysts. The surface attached Au-NPFe2O3NC nanocatalysts 
catalyzed the oxidation of TMB in the presence of H2O2 and produced a blue-colored 
complex product (naked-eye), which turned yellow after the addition of an acid to the 
reaction media. The level of p53 autoantibody was detected via measuring the intensity (UV-
visible) and amperometric current generated by the yellow product. 
 
Figure 4.  Mean responses of (a) absorbance and (b) steady-state amperometric current 
obtained for the assay with one positive (presence of p53 autoantibodies in serum) with three 
negative control samples (no target represents PBS instead of positive serum; negative 
control represents serum without p53 autoantibodies; and no secondary antibody represents 
the no IgG/ Au-NPFe2O3NC. Insets, corresponding photos for the naked eye evaluation and i-
t curves. 
 
Figure 5. Concentration dependent curve for p53 autoantibody standards provided in the 
commercial p53 autoantibody ELISA kit. Mean responses of (a) absorbance and (b) steady-
state amperometric currents obtained for the designated concentration of standard samples. 
Inset shows the corresponding linear regression curves.   
 
Figure 6. Mean responses of (a) absorbance and (b) steady-state amperometric current 
obtained p53-specific autoantibodies present in plasma samples obtained from patients with 
epithelial ovarian cancer high-grade serous subtype (EOCHGS, P4 = stage III and P3 = stage 
I) and their non-cancerous healthy patients (benign, P1 and 2). 
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